Sova Pharmaceuticals Inc. is a privately-held biopharmaceutical company founded in 2010. The company is engaged in the discovery and development of innovative therapeutics for the treatment of pain and inflammation. These areas represent large areas of unmet medical need as few new molecular targets are being pursued as candidates for the treatment of both pain and inflammation, and even fewer new drugs active against such targets have been commercialized that will benefit patients. There is increasing recognition that increased local concentrations of the gasotransmitter, hydrogen sulfide, are contributory to certain disease states characterized by pain and inflammation. Sova is dedicated to modulation of cystathionine-γ-lyase (CSE), a novel enzymatic target involved in the production of hydrogen sulfide.
View Top Employees from Sova Pharmaceuticals, Inc.Website | http://www.sovapharma.com |
Revenue | $1 million |
Employees | 3 (2 on RocketReach) |
Founded | 2010 |
Address | 11099 N Torrey Pines Rd, Ste 290, La Jolla, California 92037, US |
Phone | (858) 750-4700 |
Fax | (858) 750-4701 |
Technologies | |
Industry | Pharmaceuticals, Manufacturing General, Biotechnology, Drug Discovery, Manufacturing, Science and Engineering |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Sova Pharmaceuticals, Inc. employee's phone or email?
The Sova Pharmaceuticals, Inc. annual revenue was $1 million in 2024.
Michael North is the Vice President of Sova Pharmaceuticals, Inc..
2 people are employed at Sova Pharmaceuticals, Inc..
Sova Pharmaceuticals, Inc. is based in La Jolla, California.
The NAICS codes for Sova Pharmaceuticals, Inc. are [32, 325, 32541, 3254].
The SIC codes for Sova Pharmaceuticals, Inc. are [283, 28].